The COVID-19 pandemic has had a major impact on the healthcare formula in Japan and the Japanese economy. This article offers a review of challenges similar to those two topics. First, using data from the end of August to the end of November 2020, we verified the infection situation: by combining COVID-19 open data, Google mobility data and government statistics, we generated daily prefectural panel data and weekly. This article analyzes the effect of people’s mobility on the dynamics of COVID-19 infection and the tightening of the supply of intensive care (and intensive care) beds due to the increasing number of critically ill patients. Second, we read about the limitations of the Japanese healthcare formula. Although intensive care (ICU) teams are not designed to prevent the spread of infectious diseases, severe cases of COVID-19 require treatment in the ICU and require larger nursing staff than normal. The immediate influx of COVID-19 patients has highlighted the challenge that exists in the other definitions of beds stipulated in the Health Care Law and the medical pricing formula, creating difficulties in hospital management. In addition, the epidemic salvation formula established by the Infectious Diseases Law and the health care plan of each prefecture has been found in the existing unforeseen situation.
